Search

everythinglearnresearchcommunity

for

Search:↓

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Using finasteride with TIP extends time off period for prostate cancer patients.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Older men should openly discuss sexual health with doctors to improve their quality of life.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Male pattern baldness is common, treatable, and may be linked to heart disease and prostate cancer.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Finasteride is effective for hair loss but has controversial side effects.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Minoxidil can reduce functions related to androgen receptors.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Adherence to finasteride treatment for prostate issues is generally low.